Jenniffer Bates, APRN
Adult Health · Winter Garden, FLNPI 1720463771
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 529 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,319, 2.3 times the $2,340 reported in 2021. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 529 payments — averaging $35.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- GSK$3K
- Grifols USA, LLC$2K
- Boehringer Ingelheim$2K
- United Therapeutics Corporation$1K
- Actelion Pharmaceuticals US, Inc.$973
- plus $6K from 31 others
What the payments were for
- Consulting fees$7444%
- Food & beverage$17,93294%
- Education$3642%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 111 | $4,059 |
| GSK | 96 | $3,378 |
| Grifols USA, LLC | 58 | $1,667 |
| Boehringer Ingelheim | 34 | $1,583 |
| United Therapeutics Corporation | 11 | $1,349 |
| Actelion Pharmaceuticals US, Inc. | 18 | $973 |
| Jazz Pharmaceuticals Inc. | 16 | $956 |
| Sanofi | 24 | $719 |
| Regeneron Healthcare Solutions, Inc. | 36 | $614 |
| Amgen | 12 | $574 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $453 |
| Harmony Biosciences LLC | 5 | $338 |
| Verona Pharma, Inc. | 20 | $286 |
| Mylan Specialty L.p. | 12 | $224 |
| Insmed, Inc. | 9 | $205 |
| Lilly USA, LLC | 8 | $203 |
| Pulmonx Corporation | 1 | $141 |
| Johnson & Johnson | 2 | $140 |
| Paratek Pharmaceuticals, Inc. | 2 | $133 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $128 |
| Idorsia Pharmaceuticals US Inc | 2 | $125 |
| Ardelyx, Inc. | 1 | $121 |
| Bayer | 6 | $113 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| E.r. Squibb & Sons, L.L.C. | 1 | $96 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Electromed, Inc. | 3 | $31 |
| Novartis | 2 | $26 |
| Tactile Systems Technology Inc | 1 | $23 |
| Viatris Specialty LLC | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Merck | 1 | $15 |
| Advanced Respiratory, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$1,030
- TYVASO$969
- BREZTRI$808
- TEZSPIRE$767
- NUCALA$716
- XYWAV$504
- UPTRAVI$489
- OPSUMIT$489
- DUPIXENT$349
- AIRSUPRA$309
- Prolastin-C Liquid$288
- TRELEGY ELLIPTA$236
- OFEV$236
- Wakix$228
- Xembify$152
- CHARTIS CATHETER$141
- ZEPHYR DELIVERY CATHETER$141
- ZEPHYR ENDOBRONCHIAL VALVE$141
- PULMONX CHARTIS TABLET CONSOLE$141
- IMFINZI$125
How this compares
$19,040 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 125 | $92,684 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 36 | $25,112 |
| Spiriva RespimatTiotropium Bromide | 15 | $12,157 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $11,430 |
| SymbicortBudesonide/Formoterol Fumarate | 39 | $9,707 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $2,246 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 91 | $1,924 |
| BreynaBudesonide/Formoterol Fumarate | 13 | $1,500 |
| Montelukast Sodium | 94 | $700 |
| Fluticasone Propionate | 28 | $332 |
| Azelastine Hcl | 15 | $259 |
| Prednisone | 72 | $224 |
| Azithromycin | 20 | $125 |
| Doxycycline Monohydrate | 11 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $3,378 | $104,114144 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $4,059 | $34,81975 claims |
| Boehringer IngelheimSpiriva Respimat | $1,583 | $12,15715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Winter Garden
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.